Sofiya Latifyan

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

Eleonora Ghisoni, Alexandre Wicky, Hasna Bouchaab et al. · European Journal of Cancer · 2021 · 186 citations · Full text

Life Sciences, Immunology, Oncology +16

⁶⁸Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis

Sarah Boughdad, Sofiya Latifyan, Craig Fenwick et al. · Journal for ImmunoTherapy of Cancer · 2021 · 77 citations · Full text

Medicine, Cardiology, Nuclear Medicine +17

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

Julia Maria Ressler, Matthias Karasek, Lukas Koch et al. · Journal for ImmunoTherapy of Cancer · 2021 · 51 citations · Full text

Medicine, Dermatology, Oncology +16

Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma

Johanna Chiffelle, David Barras, Rémy Pétremand et al. · Immunity · 2024 · 43 citations

Life Sciences, Immunology, Oncology +16

Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events

Alexander Coukos, Julien Vionnet, Michel Obéid et al. · Journal for ImmunoTherapy of Cancer · 2022 · 37 citations · Full text

Medicine, Immunology, Pathology +17